Hattie Pearsey, University of Leicester. 'Zinc-alpha2-glycoprotein: a driver or a consequence of type 2 diabetes?' Host: Dan Cuthbertson
12:45pm - 1:45pm /
Friday 18th May 2018
/ Venue: Rooms G12-G15, Ground floor. William Henry Duncan Apex Building
- 0151 794 9003
- Brenda Smith
- Suitable for: Staff and students.
- Admission: Free to staff and students. No need to register.
Add this event to my calendar
Click on "Create a calendar file" and your browser will download a .ics file for this event.
Microsoft Outlook: Download the file, double-click it to open it in Outlook, then click on "Save & Close" to save it to your calendar. If that doesn't work go into Outlook, click on the File tab, then on Open & Export, then Open Calendar. Select your .ics file then click on "Save & Close".
Google Calendar: download the file, then go into your calendar. On the left where it says "Other calendars" click on the arrow icon and then click on Import calendar. Click on Browse and select the .ics file, then click on Import.
Apple Calendar: The file may open automatically with an option to save it to your calendar. If not, download the file, then you can either drag it to Calendar or import the file by going to File >Import > Import and choosing the .ics file.
Harriet Pearsey is a first year full-time PhD student at University of Leicester, working within the Leicester Diabetes Centre at Leicester General Hospital.
Her PhD is based around novel metabolic and protein markers of glucose metabolism, insulin resistance and type 2 diabetes in high risk populations.
This talk will be regarding the work Harriet has performed in the first few months of her PhD, investigating the role of the novel adipokine and lipid-mobilizing factor, zinc-alpha-2-glycoprotein, in type 2 diabetes. This talk will provide information on the studies conducted, that are ongoing, including the current collaboration with Liverpool University and future avenues of investigation.
This talk is suitable for any individual with an interest in biochemical analysis of markers relating to cardio metabolic disease and lifestyle modifications.
Her PhD is based around novel metabolic and protein markers of glucose metabolism, insulin resistance and type 2 diabetes in high risk populations.
This talk will be regarding the work Harriet has performed in the first few months of her PhD, investigating the role of the novel adipokine and lipid-mobilizing factor, zinc-alpha-2-glycoprotein, in type 2 diabetes. This talk will provide information on the studies conducted, that are ongoing, including the current collaboration with Liverpool University and future avenues of investigation.
This talk is suitable for any individual with an interest in biochemical analysis of markers relating to cardio metabolic disease and lifestyle modifications.